Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift

doi:10.1016/j.phymed.2021.153707

KIB OpenIR

	Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift
	Zhang,Xin-Tian ; Hu,Jing ; Su,Li-Hua ; Geng,Chang-An ; Chen,Ji-Jun
	2021
发表期刊	PHYTOMEDICINE
ISSN	0944-7113
卷号	91 页码:153707
摘要	Background: Artematrolide A (AR-A), a guaianolide dimer isolated from Artemisia atrovirens, demonstrated significant inhibitory effect on three human hepatoma cell lines (HepG2, Huh7 and SMMC7721). The anti-cervical cancer effect and mechanism of this compound have yet to be explored. This study is to reveal the role and mechanisms of artematrolide A on cervical cancer cells, and provide the pharmacological understanding of artematrolide A.Purpose: To investigate the function and possible mechanism of artematrolide A on cervical cancer cells in vitro.Methods: HeLa S3 and SiHa cells were treated with artematrolide A at various concentrations. In this study, MTT, colony formation, cell migration and invasion, cell cycle analysis, cell apoptosis, reactive oxygen species (ROS) detection, western blotting, enzyme activity, and lactate production of artematrolide A were evaluated.Results: Artematrolide A inhibited cell viability, proliferation, migration and invasion in a dose-dependent manner, caused cell cycle arrest in G2/M phase, and induced cell apoptosis via Bcl-2/PARP-1. The mechanism of action of artematrolide A included two aspects: artematrolide A suppressed cell proliferation by activating ROS/ERK/mTOR signaling pathway and promoted glucose metabolism from aerobic glycolysis to mitochondrial respiration by activating pyruvate dehydrogenase complex (PDC) and oxoglutarate dehydrogenase complex (OGDC) via inhibiting the activity of alkaline phosphatases (ALP).Conclusion: Artematrolide A exhibited a significant cytotoxic activity on cervical cancer cells, induced G2/M cell cycle arrest and apoptosis by activating ROS/ERK/mTOR signaling pathway and promoting metabolic shift from aerobic glycolysis to mitochondrial respiration, which suggested artematrolide A might be a potential agent for the treatment of cervical cancer.
关键词	Artemisia atrovirens Cervical cancer ERK pathway Cell metabolism ALKALINE-PHOSPHATASE SIGNALING PATHWAY DIFFERENTIATION APOPTOSIS ERK MECHANISMS
DOI	10.1016/j.phymed.2021.153707
WOS记录号	WOS:000696238900054
引用统计
文献类型	期刊论文
条目标识符	http://ir.kib.ac.cn/handle/151853/73751
专题	中国科学院昆明植物研究所
作者单位	1.[Zhang, Xin-Tian 2.Hu, Jing 3.Su, Li-Hua 4.Geng, Chang-An 5.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Yunnan Key Lab Nat Med Chem, Kunming 650201, Yunnan, Peoples R China 6.[Su, Li-Hua 7.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
推荐引用方式 GB/T 7714	Zhang,Xin-Tian,Hu,Jing,Su,Li-Hua,et al. Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift[J]. PHYTOMEDICINE,2021,91:153707.
APA	Zhang,Xin-Tian,Hu,Jing,Su,Li-Hua,Geng,Chang-An,&Chen,Ji-Jun.(2021).Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift.PHYTOMEDICINE,91,153707.
MLA	Zhang,Xin-Tian,et al."Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift".PHYTOMEDICINE 91(2021):153707.

条目包含的文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
116-H15-010-2021-张心湉（6313KB）	期刊论文	出版稿	开放获取	CC BY-NC-SA	浏览请求全文